X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2004) 2004
Publication (135) 135
Book Review (27) 27
Magazine Article (14) 14
Book / eBook (11) 11
Book Chapter (8) 8
Conference Proceeding (6) 6
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1582) 1582
arsenicals - therapeutic use (1291) 1291
oxides - therapeutic use (694) 694
index medicus (676) 676
male (629) 629
animals (623) 623
arsenic trioxide (611) 611
female (607) 607
antineoplastic agents - therapeutic use (530) 530
leukemia, promyelocytic, acute - drug therapy (522) 522
acute promyelocytic leukemia (457) 457
oncology (446) 446
arsenicals - pharmacology (431) 431
arsenic (420) 420
adult (385) 385
hematology (367) 367
apoptosis (351) 351
arsenicals - administration & dosage (344) 344
middle aged (341) 341
oxides - pharmacology (324) 324
arsenicals - adverse effects (286) 286
oxides - administration & dosage (277) 277
apoptosis - drug effects (262) 262
mice (251) 251
antineoplastic combined chemotherapy protocols - therapeutic use (250) 250
treatment outcome (245) 245
antineoplastic agents - pharmacology (234) 234
cancer (233) 233
aged (224) 224
cell line, tumor (209) 209
trans-retinoic acid (202) 202
chemotherapy (198) 198
oxides - adverse effects (198) 198
tretinoin - therapeutic use (194) 194
leukemia (183) 183
arsenicals (179) 179
adolescent (173) 173
pharmacology & pharmacy (161) 161
remission induction (147) 147
toxicology (143) 143
in-vitro (141) 141
antineoplastic agents - adverse effects (137) 137
leukemia, promyelocytic, acute - pathology (130) 130
therapy (127) 127
tretinoin - administration & dosage (124) 124
recurrence (121) 121
dose-response relationship, drug (116) 116
cells (115) 115
leukemia, promyelocytic, acute - genetics (114) 114
child (112) 112
research (99) 99
antineoplastic agents - administration & dosage (96) 96
health aspects (93) 93
toxicity (93) 93
as2o3 (92) 92
cell proliferation - drug effects (92) 92
drug synergism (92) 92
induced apoptosis (92) 92
expression (91) 91
rats (90) 90
care and treatment (87) 87
acute myeloid-leukemia (84) 84
clinical trials as topic (84) 84
time factors (84) 84
tumor cells, cultured (82) 82
young adult (82) 82
prognosis (81) 81
remission (81) 81
trypanosomiasis, african - drug therapy (81) 81
activation (79) 79
proteins (79) 79
retinoic acid (77) 77
analysis (74) 74
drug resistance, neoplasm (74) 74
medicine (74) 74
inhibition (73) 73
leukemia, promyelocytic, acute - metabolism (73) 73
trypanocidal agents - therapeutic use (73) 73
oxidative stress (72) 72
article (71) 71
cell biology (71) 71
research article (69) 69
arsenicals - pharmacokinetics (68) 68
biochemistry & molecular biology (68) 68
cell survival - drug effects (68) 68
drug therapy, combination (68) 68
differentiation (67) 67
hematology, oncology and palliative medicine (66) 66
disease-free survival (65) 65
cell differentiation - drug effects (64) 64
down-regulation (63) 63
multiple myeloma - drug therapy (62) 62
oxides - toxicity (62) 62
drug therapy (60) 60
multidisciplinary sciences (60) 60
reactive oxygen species - metabolism (60) 60
follow-up studies (59) 59
growth-inhibition (59) 59
medicine & public health (59) 59
pml (59) 59
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1719) 1719
Chinese (75) 75
French (67) 67
German (41) 41
Russian (35) 35
Spanish (25) 25
Italian (19) 19
Japanese (16) 16
Bulgarian (7) 7
Polish (7) 7
Dutch (6) 6
Portuguese (5) 5
Romanian (3) 3
Czech (2) 2
Danish (2) 2
Hungarian (2) 2
Swedish (2) 2
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1570 - 1580
Journal Article
Cancer Cell, ISSN 1535-6108, 01/2013, Volume 23, Issue 1, pp. 23 - 34
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 111 - 121
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1295 - 1305
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 12/2017, Volume 268, pp. 92 - 101
Myelodysplastic syndromes (MDS) are a diverse group of bone marrow disorders and clonal hematopoietic stem cell disorders characterized by abnormal blood... 
Bone marrow | Decitabine | Arsenic trioxide | Delivery | Nanoparticle | Myelodysplastic syndrome | APOPTOSIS | DNA METHYLATION | DRUG-DELIVERY | 5-AZACYTIDINE | COMBINATION | CANCER | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | RETINOIC ACID | PHARMACOLOGY & PHARMACY | POLYMER HYBRID NANOPARTICLES | ACUTE PROMYELOCYTIC LEUKEMIA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanoparticles - chemistry | Apoptosis - drug effects | Oxides - chemistry | Azacitidine - chemistry | Phosphatidylethanolamines - therapeutic use | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyethylene Glycols - therapeutic use | Alendronate - chemistry | Alendronate - therapeutic use | Tissue Distribution | Arsenicals - therapeutic use | Nanoparticles - therapeutic use | Bone and Bones - metabolism | Phosphatidylethanolamines - pharmacokinetics | Bone Marrow Cells - drug effects | Antineoplastic Agents - pharmacokinetics | Arsenicals - pharmacokinetics | Alendronate - pharmacokinetics | Myelodysplastic Syndromes - drug therapy | Oxides - administration & dosage | Azacitidine - administration & dosage | Oxides - therapeutic use | Cell Survival - drug effects | Arsenic Trioxide | Azacitidine - pharmacokinetics | Myelodysplastic Syndromes - metabolism | Cells, Cultured | Polyethylene Glycols - pharmacokinetics | Azacitidine - analogs & derivatives | Mice, Transgenic | Phosphatidylethanolamines - administration & dosage | Antineoplastic Agents - chemistry | Polyethylene Glycols - administration & dosage | Oxides - pharmacokinetics | Arsenicals - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Arsenicals - chemistry | Nanoparticles - administration & dosage | Phosphatidylethanolamines - chemistry | Alendronate - administration & dosage | Azacitidine - therapeutic use | Medical research | Medical colleges | Medical examination | Arsenic | Analysis | Medicine, Experimental | Hematopoietic stem cells | Blood | Index Medicus | delivery | nanoparticle | decitabine | arsenic trioxide | bone marrow
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2012, Volume 87, Issue 6, pp. 596 - 603
Acute promyelocytic leukemia (APL) has evolved from being a deadly to a highly curable disease, due totargeted molecular therapy with all‐trans retinoic acid... 
COMPLICATING INDUCTION THERAPY | VEIN-THROMBOSIS | INTRAVASCULAR COAGULATION | MICROGRANULAR VARIANT | TRANS-RETINOIC ACID | EARLY DEATH RATE | BUDD-CHIARI SYNDROME | FATAL THROMBOEMBOLISM | HEMATOLOGY | REMISSION INDUCTION | ARSENIC TRIOXIDE | Recombinant Proteins - therapeutic use | Antifibrinolytic Agents - therapeutic use | Plasma | Humans | Hemorrhage - mortality | Heparin - therapeutic use | Antineoplastic Agents - therapeutic use | Hemorrhage - prevention & control | Factor VIIa - therapeutic use | Heparin - adverse effects | Arsenicals - therapeutic use | Leukemia, Promyelocytic, Acute - metabolism | Multicenter Studies as Topic | Neoplasm Proteins - secretion | Antineoplastic Agents - adverse effects | Cysteine Endopeptidases - secretion | Hemorrhage - etiology | Treatment Failure | Factor VIII - therapeutic use | Oxides - therapeutic use | Platelet Transfusion | Disseminated Intravascular Coagulation - diagnosis | Clinical Trials as Topic | Combined Modality Therapy | Disseminated Intravascular Coagulation - blood | Fibrinolysis | Platelet Count | Tretinoin - therapeutic use | Disseminated Intravascular Coagulation - etiology | Thrombosis - etiology | Fibrinogen - analysis | Blood Coagulation Tests | Tretinoin - adverse effects | Fibrinogen - therapeutic use | Leukemia, Promyelocytic, Acute - complications | Leukemia, Promyelocytic, Acute - drug therapy | Thromboplastin - secretion
Journal Article